Amedeo Smart

Free Medical Literature Service


 

Amedeo

Drug Resistance

  Free Subscription

Articles published in
J Infect Dis
    May 2026
  1. ARIAS CA
    The Maxwell Finland Lecture 2025: Antimicrobial Resistance At The Bedside: Translating Science Into Patient Outcomes.
    J Infect Dis. 2026 May 26:jiag273. doi: 10.1093.
    >> Share

  2. COLDBECK-SHACKLEY RC, Flynn E, Mudhar AK, Taouk ML, et al
    Increased Diversity and Introduction of Multidrug-Resistant Strains of Neisseria gonorrhoeae Following Cessation of COVID-19 Pandemic-Related Travel Restrictions: An Observational Genomic Epidemiologic Study.
    J Infect Dis. 2026;233:e1130-e1140.
    >> Share

  3. FONTON P, Sierra R, Martischang R, Nguyen A, et al
    Epidemiological and Molecular Surveillance of Multiresistant Citrobacter freundii Complex in a Tertiary Care Hospital: A Retrospective Cohort Study.
    J Infect Dis. 2026;233:e1181-e1192.
    >> Share

  4. CHERUKUMILLI S, Keita AM, Still W, Wei KC, et al
    Longitudinal Trends in Pediatric Non-Salmonella Gram-Negative Enterobacterales Infections at a Tertiary Care Center in West Africa, 2005-2023.
    J Infect Dis. 2026;233:946-956.
    >> Share

  5. MATTHEWS LG, Vodstrcil LA, Wild NL, Plummer EL, et al
    Declining efficacy of moxifloxacin for Mycoplasma genitalium infection: time for fluoroquinolone-resistance guided therapy?
    J Infect Dis. 2026 May 8:jiag251. doi: 10.1093.
    >> Share

    April 2026
  6. SEERAM D, Park H, Abrams JA, Uhlemann AC, et al
    Vancomycin-resistant Enterococcus often spreads from hospitalized patients into the local environment and less often spreads from the environment into patients.
    J Infect Dis. 2026 Apr 28:jiag240. doi: 10.1093.
    >> Share

  7. MOESER MJ, Council OD, Long N, Kincer L, et al
    A New Type of Nonsuppressible Viremia Produced by HIV-Infected Macrophage.
    J Infect Dis. 2026 Apr 22:jiag171. doi: 10.1093.
    >> Share

  8. KIMBLE AD, Manabe YC, Melendez JH
    Evidence-based assessment of the role of pharyngeal gonorrhea and commensal Neisseria species in the emergence of antimicrobial resistance in Neisseria gonorrhoeae: Data gaps and future research.
    J Infect Dis. 2026 Apr 3:jiag197. doi: 10.1093.
    >> Share

    March 2026
  9. TAM KK, Suster CJE, Fong W, Golubchik T, et al
    Genomic Surveillance Reveals Emergence and Spread of Macrolide-Resistant Mycoplasma pneumoniae in Australia During the 2023-2024 Epidemic.
    J Infect Dis. 2026 Mar 21:jiag163. doi: 10.1093.
    >> Share

  10. WANG J, Zhang X, Zhang Y, Xie Q, et al
    Emergence of Carbapenem-Resistant Escherichia coli Coharboring blaCTX-M-199 and Penicillin-Binding Protein 3 Insertion Conferring Increased Aztreonam/Avibactam Resistance in South China.
    J Infect Dis. 2026;233.
    >> Share

  11. ZHANG Y, He J, Sun L, Yu Q, et al
    Molecular Epidemiology and Persistence of Multidrug-Resistant Acinetobacter baumannii in Zhejiang, China (2015-2020): Insights Into Resistance, Virulence, and Transmission Dynamics.
    J Infect Dis. 2026;233.
    >> Share

  12. ZHOU J, Tang X, He L, Zhang F, et al
    Molecular Mechanisms of beta-Lactam Resistance and Its Contribution to Multidrug Resistance in Helicobacter pylori.
    J Infect Dis. 2026;233.
    >> Share

  13. LIANG L, Feng Y, Jiang Y, Zhou W, et al
    New Delhi Metallo-beta-Lactamase Carbapenem-Resistant Klebsiella pneumoniae in Neonates: A Genome-Based Surveillance Study.
    J Infect Dis. 2026;233.
    >> Share

  14. GUO Y, Ding L, Zhou Y, Ren X, et al
    Trends of Carbapenem-Resistant Gram-negative Bacteria in China: A Surveillance Study Between 2015 and 2024.
    J Infect Dis. 2026;233.
    >> Share

  15. ZENG Y, He Y, Ma K, Feng Y, et al
    Aztreonam-Avibactam Resistance Due to Synergistic Interplay of ampC-Related Mutations in Carbapenem-Resistant Enterobacter spp.
    J Infect Dis. 2026;233.
    >> Share

  16. QIN J, Feng Y, Yang Y, McNally A, et al
    OmpK35 and OmpK36 Deficiencies Driving High-level Carbapenem Resistance in ST11 Klebsiella Pneumoniae.
    J Infect Dis. 2026;233.
    >> Share

  17. LI Y, Cai H, Hua X, Yu Y, et al
    Challenges and Strategies in Managing beta-Lactam-Resistant Pseudomonas aeruginosa in China.
    J Infect Dis. 2026;233.
    >> Share

  18. LI J, Fang Q, Luo H, Feng Y, et al
    Isolation of Lytic Bacteriophages Against Carbapenem-Resistant Klebsiella pneumoniae of Capsular Type KL64 From Water Collected at Multiple Sites Across China.
    J Infect Dis. 2026;233.
    >> Share

  19. ZHANG B, Xu W, Zhang X, Zhang Q, et al
    Reduced Susceptibility to Cefepime-Taniborbactam in Carbapenem-Resistant Klebsiella pneumoniae Attributed to Penicillin-Binding Protein 3 Modifications.
    J Infect Dis. 2026;233.
    >> Share

  20. LIAO Q, Ma Z, Kang M, Xie Y, et al
    Clinical and Molecular Characteristics of Carbapenem-Resistant Klebsiella pneumoniae Causing Bloodstream Infection in a Chinese Teaching Hospital.
    J Infect Dis. 2026;233.
    >> Share

  21. HU Y, Fang Q, Zhang L, He Y, et al
    Clinical Outcomes in Hypervirulent Carbapenem-Resistant Klebsiella pneumoniae Infection: A Cohort Study.
    J Infect Dis. 2026;233.
    >> Share

  22. YANG Y, Qin J, Hu Y, Wang J, et al
    Carbapenem-Resistant Klebsiella pneumoniae of Sequence Type 11: A Scoping Review.
    J Infect Dis. 2026;233.
    >> Share

    February 2026
  23. MARIN JEO, Boza MJL, Camargo CH, Campos KR, et al
    Stepwise Evolution of Triple Antimicrobial Resistance in Neisseria meningitidis.
    J Infect Dis. 2026 Feb 23:jiag113. doi: 10.1093.
    >> Share

  24. HALL CW, Waglechner N, Choi E, Aftanas P, et al
    Evaluation of Phenotypic and Genotypic Susceptibility Testing Methods for Newer beta-lactam/beta-lactamase Inhibitor Combinations in Multidrug Resistant Pseudomonas aeruginosa.
    J Infect Dis. 2026;233:e541-e549.
    >> Share

  25. AZNAR FERNANDEZ M, Rodriguez-Villodres A, Gomez-Gomez MJ, Cisneros JM, et al
    Novel KPC-2 Plasmid in a Clinical Salmonella Rissen Selected by Antibiotic Pressure.
    J Infect Dis. 2026;233:328-333.
    >> Share

  26. CAMPBELL P
    The Influence of National Antibiotic Consumption on Neisseria gonorrhoeae Antibiotic Resistance in Norway, 2003-2024.
    J Infect Dis. 2026 Feb 11:jiag076. doi: 10.1093.
    >> Share

  27. XU L, Li J, Wu W, Dou L, et al
    Decoding hypervirulence in carbapenem-resistant Klebsiella pneumoniae: genomic and phenotypic profiling reveals capsular polysaccharide as a key driver of pathogenicity.
    J Infect Dis. 2026 Feb 9:jiag075. doi: 10.1093.
    >> Share

  28. VILLAFUERTE D, Fall A, Akin E, Werner AP, et al
    Genomic Evolution of Influenza A Virus During the 2024-2025 Season, the Johns Hopkins Health System: Antigenic Drift Reduces Serum Neutralization.
    J Infect Dis. 2026 Feb 4:jiag069. doi: 10.1093.
    >> Share

    January 2026
  29. MC GANN P, Luo TL, Martin MJ, Dao HD, et al
    Foreign Combatants Wounded in Ukraine Colonized by Extensively Drug-Resistant Organisms: A Potential Source of Global Dissemination.
    J Infect Dis. 2026;233:e183-e191.
    >> Share

  30. KUSTER S, Gottlich C, O'Shea T, Ghert M, et al
    The Burden of Surgical Site Infections With Pathogens Presumably Resistant to Perioperative Prophylaxis in Orthopedic Tumor Surgery: Secondary Analysis of the Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) Trial.
    J Infect Dis. 2026;233:e174-e182.
    >> Share

  31. HURST JR, Addo M, Li A, Khera SS, et al
    Monkeypox Virus Shedding Despite Tecovirimat Treatment in a Cohort in Toronto, Canada.
    J Infect Dis. 2026;233:e132-e139.
    >> Share

  32. LIBBY TE, Karani A, Tickell KD, Akech D, et al
    The effect of a 5-day course of azithromycin on Streptococcus pneumoniae carriage and antimicrobial resistance among Kenyan children discharged from hospital.
    J Infect Dis. 2026 Jan 16:jiag028. doi: 10.1093.
    >> Share

    December 2025
  33. AGUIRRE M, Ayala D, Garcia JI, Martinez-Lopez YE, et al
    Accuracy of the phenotypic 1G test to detect Mycobacterium tuberculosis and drug resistance from sputa in the US-Mexico border.
    J Infect Dis. 2025 Dec 23:jiaf638. doi: 10.1093.
    >> Share

    November 2025
  34. TANG X, Ying J, Shen Y, Song X, et al
    Prevalence and Molecular Mechanisms of Amoxicillin Resistance Among Clinical Helicobacter pylori Isolates in Southwest China.
    J Infect Dis. 2025;232.
    >> Share

  35. ZHANG J, Wang Y, Chen L, Zhang Q, et al
    Antimicrobial Resistance of Helicobacter pylori Among Chinese Yi Population.
    J Infect Dis. 2025;232.
    >> Share

  36. TANG X, Shen Y, Song X, He B, et al
    Comparative Evaluation of Modified Agar Dilution and Standard Agar Dilution Methods for Antimicrobial Susceptibility Testing of Helicobacter pylori.
    J Infect Dis. 2025;232.
    >> Share

  37. LIANG C, Zhou Y, Li Y, Xu M, et al
    Follow-up and Analysis of Helicobacter pylori Antibioic Resistance in the South Area of Sichuan Province.
    J Infect Dis. 2025;232.
    >> Share

  38. ZHOU JP, Yang TK, Li J, Tay A, et al
    Rifabutin-Containing Therapy for Helicobacter pylori Eradication: A Review.
    J Infect Dis. 2025;232.
    >> Share

  39. ZHANG Y, Liu K, Song X, Shen Y, et al
    Antimicrobial Resistance Patterns of Clinical Helicobacter pylori Isolates From Gastric Cancer Patients.
    J Infect Dis. 2025;232.
    >> Share

  40. PODKOWIK M, Tillman A, Takats C, Carion H, et al
    CRISPR-Cas-associated SCCmec variants in methicillin-resistant Staphylococcus aureus evade rapid diagnostic detection.
    J Infect Dis. 2025 Nov 19:jiaf575. doi: 10.1093.
    >> Share

  41. LENZ S, Biswas S, Terry I, Tran-Basha L, et al
    Detection of Carbapenem-Resistant Bacteria in Skilled Nursing Facility Wastewater.
    J Infect Dis. 2025 Nov 18:jiaf534. doi: 10.1093.
    >> Share

  42. ARUN B, Liu E, Valle Q, Sharma R, et al
    Ampicillin/Sulbactam in Combination with Ceftazidime/Avibactam against Metallo-beta-Lactamase-Producing Carbapenem-Resistant Acinetobacter baumannii: A Genomics-Informed Mechanism-Based Model.
    J Infect Dis. 2025 Nov 12:jiaf567. doi: 10.1093.
    >> Share

  43. SELZER L, Demirdjian S, Falkard B, Li J, et al
    Resistance Analysis of Low-Level Virologic Rebound During HIV-1 Treatment with Lenacapavir and Broadly Neutralizing Antibodies Teropavimab and Zinlirvimab.
    J Infect Dis. 2025 Nov 5:jiaf559. doi: 10.1093.
    >> Share

  44. JIANG JH, Lim CX, Lai X, Kostoulias X, et al
    Daptomycin-Loaded Nanocarriers Facilitate Synergistic Killing of Methicillin-Resistant Staphylococcus aureus via Lipid-Mediated Interactions and Targeting.
    J Infect Dis. 2025 Nov 4:jiaf492. doi: 10.1093.
    >> Share

    October 2025
  45. COX S, Andreatta K, Hendricks MR, Li J, et al
    Resistance Analyses of Lenacapavir, Emtricitabine/Tenofovir Alafenamide and Emtricitabine/Tenofovir Disoproxil Fumarate in the PURPOSE 1 and 2 Studies.
    J Infect Dis. 2025 Oct 24:jiaf533. doi: 10.1093.
    >> Share

  46. LI J, Jin Y, Wang Y, Shang L, et al
    New Developments in Influenza Polymerase Inhibitors.
    J Infect Dis. 2025;232.
    >> Share

  47. PASCO R, Hayden FG, Meyers LA
    Modeling Influenza Antiviral Strategies: Reducing Burden and Preventing Resistance.
    J Infect Dis. 2025;232.
    >> Share

  48. HELDMAN MR, Boeckh MJ, Ison MG
    Influenza Antivirals for Prevention and Treatment in Immunocompromised People.
    J Infect Dis. 2025;232.
    >> Share

  49. TAKASHITA E, Wolfe CR, Jones JC
    Laboratory Methods for Monitoring Influenza Antiviral Resistance.
    J Infect Dis. 2025;232.
    >> Share

  50. KASAI M, Nakano S, Koide S, Otake S, et al
    Prevalence of candidate vaccine targets and genomic features of pediatric invasive Streptococcus agalactiae in Japan.
    J Infect Dis. 2025 Oct 9:jiaf491. doi: 10.1093.
    >> Share

    September 2025
  51. FLERES G, Cheng S, Badrane H, Dupont CL, et al
    Blood cultures contain populations of genetically diverse Candida albicans strains that may differ in echinocandin tolerance and fitness.
    J Infect Dis. 2025 Sep 30:jiaf495. doi: 10.1093.
    >> Share

  52. KELLY C, Lester JS, Bradshaw D, Bibby DF, et al
    Real-world prevalence of non-integrase INSTI resistance-associated mutations and virological outcomes in people who have recently acquired HIV-1 in the UK.
    J Infect Dis. 2025 Sep 26:jiaf500. doi: 10.1093.
    >> Share

  53. PORETSKY RS, Gonzalez DS, Horton A, Schoeny M, et al
    Establishing a Practical Approach to Sewer Monitoring for Antimicrobial Resistance Genes and Organisms at Healthcare Facilities.
    J Infect Dis. 2025 Sep 24:jiaf434. doi: 10.1093.
    >> Share

  54. SRIDHAR S, Worby CJ, Bronson RA, Turbett SE, et al
    Insights Into Global Antimicrobial Resistance Dynamics Through the Sequencing of Enteric Bacteria From US International Travelers.
    J Infect Dis. 2025 Sep 24:jiaf469. doi: 10.1093.
    >> Share

  55. CARR MA, Chou SR, Sun J, LaRock DL, et al
    Therapeutic Inhibition of Metalloproteases by Tetracyclines During Infection by Multidrug-Resistant Pseudomonas.
    J Infect Dis. 2025;232:e416-e420.
    >> Share

  56. GONTJES KJ, Singh A, Sansom SE, Boyko JD, et al
    Phylogenetic context of antibiotic resistance provides insights into the dynamics of resistance emergence and spread.
    J Infect Dis. 2025 Sep 15:jiaf478. doi: 10.1093.
    >> Share

    August 2025
  57. ROBERTS M, Davis P
    Doxycycline post-exposure prophylaxis and off-target antimicrobial resistance: potential amplification within sexual networks.
    J Infect Dis. 2025 Aug 20:jiaf439. doi: 10.1093.
    >> Share

  58. WATKINS RR, Lemonovich TL, Vila AJ, Bonomo RA, et al
    Cefepime-Taniborbactam-a Novel Combination Therapy for Multidrug-Resistant Pathogens.
    J Infect Dis. 2025;232:278-284.
    >> Share

  59. CHOUDHURY NR, Urwin L, Salamaga B, Prince LR, et al
    Determining the importance of the stringent response for methicillin-resistant Staphylococcus aureus virulence in vivo.
    J Infect Dis. 2025 Aug 8:jiaf421. doi: 10.1093.
    >> Share

  60. LIAO CH, Huang YL, Ioerger T, Lim KS, et al
    Genomic and phenotypic insights into antibiotic resistance and virulence of Klebsiella pneumoniae from the environment in Southern Taiwan.
    J Infect Dis. 2025 Aug 1:jiaf396. doi: 10.1093.
    >> Share

    July 2025
  61. MARANO RBM, Oster Y, Benenson S, Motro Y, et al
    An Omics-Guided Investigation of a Hospital Outbreak Caused by blaNDM-1-Producing Pseudocitrobacter faecalis.
    J Infect Dis. 2025;232:e17-e26.
    >> Share

  62. LAUMEN JGE, Hieu VN, Nhung PH, Vandelannoote K, et al
    High Prevalence of Ceftriaxone-Resistant Neisseria gonorrhoeae in Hanoi, Vietnam, 2023-2024.
    J Infect Dis. 2025;232:e73-e77.
    >> Share

  63. CAILLAULT A, Softic L, Bay P, Ly A, et al
    Molecular Characterization of Respiratory Syncytial Virus Infections in Elderly Patients During the 2023-2024 Season in the Era of Nirsevimab Introduction.
    J Infect Dis. 2025;232:199-202.
    >> Share

  64. SHIMUTA K, Ohama Y, Ito S, Hoshina S, et al
    Emergence of Ceftriaxone-Resistant Neisseria gonorrhoeae Through Horizontal Gene Transfer Among Neisseria Species.
    J Infect Dis. 2025;232:152-161.
    >> Share

  65. WANG TW, Putnam N, Johnson JK, Jabra-Rizk MA, et al
    In vivo evolution of Candida auris multi-drug resistance in a patient receiving antifungal treatment.
    J Infect Dis. 2025 Jul 30:jiaf394. doi: 10.1093.
    >> Share

  66. TALBOT BM, Jacko NF, Hofstetter KS, Alahakoon T, et al
    Methicillin-Resistant Staphylococcus aureus Bacteremia Relapses Show Diverse Genomic Profiles but Convergence in Bacteremia-Associated Genes.
    J Infect Dis. 2025 Jul 25:jiaf352. doi: 10.1093.
    >> Share

  67. VO-QUANG E, Rodriguez C, Ly A, Ndow G, et al
    Virological tools fail to properly identify "unusual" hepatitis C virus subtypes resistant to direct-acting antiviral drugs in The Gambia.
    J Infect Dis. 2025 Jul 22:jiaf378. doi: 10.1093.
    >> Share

    June 2025
  68. NORGAARD JC, Marandi RZ, Ilett EE, Gulay A, et al
    The gut microbiome and its resistome as predictors of clinical infections and phenotypic antibiotic resistance in hematopoietic stem cell transplant recipients.
    J Infect Dis. 2025 Jun 23:jiaf330. doi: 10.1093.
    >> Share

  69. DOORLEY LA, Meza-Perez V, Jones SJ, Rybak JM, et al
    A Candidozyma (Candida) auris-Optimized Episomal Plasmid-Induced Cas9-Editing System Reveals the Direct Impact of the S639F-Encoding FKS1 Mutation.
    J Infect Dis. 2025 Jun 17:jiaf285. doi: 10.1093.
    >> Share

  70. BUSTION AE, Ernest JP, Kaya F, Silva C, et al
    The kinetics of bedaquiline diffusion in tuberculous cavities open a window for emergence of resistance.
    J Infect Dis. 2025 Jun 4:jiaf303. doi: 10.1093.
    >> Share

  71. DESCHENES NM, Perez-Vargas J, Zhong Z, Thomas M, et al
    Functional and structural characterization of treatment-emergent nirmatrelvir resistance mutations at low frequencies in the main protease (Mpro) reveals a unique evolutionary route for SARS-CoV-2 to gain resistance.
    J Infect Dis. 2025 Jun 3:jiaf294. doi: 10.1093.
    >> Share

  72. YANG T, Beach KE, Zhu C, Gan M, et al
    Genomic Analysis of Global Mycobacterium abscessus Isolates Reveals Ongoing Evolution of Drug Resistance-Associated Genes.
    J Infect Dis. 2025;231:1150-1154.
    >> Share

    May 2025
  73. LI Y, Stellfox ME, Evans KM, Mills EG, et al
    Functional genomics of antibiotic susceptibility in Enterococcus faecalis from infective endocarditis.
    J Infect Dis. 2025 May 30:jiaf272. doi: 10.1093.
    >> Share

  74. MCHUGH J, Chesdachai S, Dunsirn M, Wengenack N, et al
    Increasing Fluconazole Resistance in Candida parapsilosis: A 10-Year Analysis of Blood Culture Isolates at a US Reference Laboratory (2015-2024).
    J Infect Dis. 2025 May 13:jiaf249. doi: 10.1093.
    >> Share

    April 2025
  75. MOGENI P, Ochieng JB, Atlas HE, Tickell KD, et al
    Impact of macrolide resistance on azithromycin for prevention of rehospitalization or death among children discharged from hospitals in Western Kenya.
    J Infect Dis. 2025 Apr 21:jiaf208. doi: 10.1093.
    >> Share

  76. PARK H, Abrams JA, Uhlemann AC, Freedberg DE, et al
    Gut colonization with vancomycin-resistant Enterococcus shapes the gut microbiome in the intensive care unit.
    J Infect Dis. 2025 Apr 16:jiaf194. doi: 10.1093.
    >> Share

  77. MASTERS TL, Toney NC, Ewing TO, McAllister GA, et al
    Genomic Epidemiology of Extrapulmonary Nontuberculous Mycobacteria Isolates at Emerging Infections Program Sites-United States, 2019-2020.
    J Infect Dis. 2025;231:902-912.
    >> Share

    March 2025
  78. PARAU G, Parks HJ, Anderson AJG, Bisaro F, et al
    Clinical isolates of antimicrobial resistant Enterobacter species can persist in human macrophages without replication and overt cellular cytotoxicity.
    J Infect Dis. 2025 Mar 3:jiaf099. doi: 10.1093.
    >> Share

    February 2025
  79. LEVENE RE, DeVincenzo J, Conery AL, Ahmad A, et al
    EDP-938 Has a High Barrier to Resistance in Healthy Adults Experimentally Infected with Respiratory Syncytial Virus.
    J Infect Dis. 2025;231:e290-e298.
    >> Share

  80. GASPAR C, Rios P, Moeller TD
    Landscape of Bacterial Enteric Disease and Traveler s Diarrhea in South America.
    J Infect Dis. 2025;231.
    >> Share

    January 2025
  81. MARGOT NA, Jogiraju V, Pennetzdorfer N, Naik V, et al
    Resistance Analyses in Heavily Treatment-Experienced People with HIV Treated with the Novel HIV Capsid Inhibitor Lenacapavir After 2 years.
    J Infect Dis. 2025 Jan 28:jiaf050. doi: 10.1093.
    >> Share

  82. JANKEEL A, Perez-Parra G, Khetarpal AK, Alvarado IA, et al
    Enhanced Killing of Methicillin-Resistant Staphylococcus aureus with Ceftaroline or Vancomycin in Combination with Carbapenems.
    J Infect Dis. 2025 Jan 8:jiaf010. doi: 10.1093.
    >> Share

    December 2024
  83. LI Y, Mishra NN, Chen L, Manna AC, et al
    Phage-Encoded Virulence Factor, Gp05, Alters Membrane Phospholipids and Reduces Antimicrobial Susceptibility in Methicillin-Resistant Staphylococcus aureus.
    J Infect Dis. 2024 Dec 31:jiae640. doi: 10.1093.
    >> Share

  84. NTOZINI B, Walaza S, Metcalf B, Hazelhurst S, et al
    Molecular epidemiology of invasive group B Streptococcus in South Africa, 2019-2020.
    J Infect Dis. 2024 Dec 31:jiae633. doi: 10.1093.
    >> Share

  85. MITTELSTAEDT R, Kanjilal S, Helekal D, Robbins GK, et al
    Staphylococcus aureus Tetracycline Resistance and Co-resistance in a Doxy-PEP-Eligible Population.
    J Infect Dis. 2024 Dec 24:jiae634. doi: 10.1093.
    >> Share

  86. MIKHARI RL, Meiring S, de Gouveia L, Chan WY, et al
    Genomic Diversity and Antimicrobial Susceptibility of Invasive Neisseria meningitidis in South Africa, 2016-2021.
    J Infect Dis. 2024;230:e1311-e1321.
    >> Share

    November 2024
  87. JACQUELINE C, Minetti C, Monzon Fernandez S, Silveira L, et al
    Genomic epidemiology of fluoroquinolone-resistant strains of Shigella sonnei and Shigella flexneri in the Iberian Peninsula from 2015 to 2022.
    J Infect Dis. 2024 Nov 29:jiae596. doi: 10.1093.
    >> Share

    October 2024
  88. MACLEAN AKW, Morrow S, Niu F, Hanson ND, et al
    What Contributes to the Minimum Inhibitory Concentration? Beyond beta-Lactamase Gene Detection in Klebsiella pneumoniae.
    J Infect Dis. 2024;230:e777-e788.
    >> Share

  89. SANSOM SE, Shimasaki T, Dangana T, Lin MY, et al
    Comparison of Daily Versus Admission and Discharge Surveillance Cultures for Multidrug-Resistant Organism Detection in an Intensive Care Unit.
    J Infect Dis. 2024;230:807-815.
    >> Share

  90. RAJAGOPALAN S, Rourke AK, Asare E, Kohlerschmidt DJ, et al
    Engineered Mycobacteriophage TM4::GeNL Rapidly Determines Bedaquiline, Pretomanid, Linezolid, Rifampicin, and Clofazimine Sensitivity in Mycobacterium tuberculosis Clinical Isolates.
    J Infect Dis. 2024 Oct 16:jiae438. doi: 10.1093.
    >> Share

  91. GAWOR J, Zuchniewicz K, Ojeda Saavedra M, Beres SB, et al
    ICESp1109, a novel hybrid Integrative Conjugative Element of macrolide-resistant Streptococcus pyogenes serotype M77 collected between 2003 and 2017 in Poland.
    J Infect Dis. 2024 Oct 12:jiae473. doi: 10.1093.
    >> Share

    September 2024
  92. CHOU S, Winston DJ, Avery RK, Cordonnier C, et al
    Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection.
    J Infect Dis. 2024 Sep 20:jiae469. doi: 10.1093.
    >> Share

    August 2024
  93. NAGELE K, Battig V, Gosert R, Walti CS, et al
    Revealing the unseen: next generation sequencing for early detection of drug-resistant cytomegalovirus variants upon letermovir prophylaxis failure.
    J Infect Dis. 2024 Aug 30:jiae414. doi: 10.1093.
    >> Share

  94. YE J, Dong Y, Lan Y, Chen J, et al
    Trends and Patterns of HIV Transmitted Drug Resistance in China From 2018 to 2023.
    J Infect Dis. 2024 Aug 27:jiae303. doi: 10.1093.
    >> Share

  95. YEK C, Lon C, Chea S, Lay S, et al
    Bacterial Genomics for National Antimicrobial Resistance Surveillance in Cambodia.
    J Infect Dis. 2024 Aug 20:jiae417. doi: 10.1093.
    >> Share

  96. CHOUDHARY MC, Deo R, Evering TH, Chew KW, et al
    Characterization of Treatment Resistance and Viral Kinetics in the Setting of Single-Active Versus Dual-Active Monoclonal Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2.
    J Infect Dis. 2024;230:394-402.
    >> Share

  97. CHOCHUA S, Beall B, Lin W, Tran T, et al
    The emergent invasive serotype 4 ST10172 strain acquires vanG type vancomycin-resistance element: A case of a 66-year-old with bacteremic pneumococcal pneumonia.
    J Infect Dis. 2024 Aug 8:jiae393. doi: 10.1093.
    >> Share

    July 2024
  98. TANTALO LC, Luetkemeyer A, Lieberman NAP, Nunley BE, et al
    Long-term in vitro exposure of Treponema pallidum to sub-bactericidal doxycycline did not induce resistance: Implications for doxy-PEP and syphilis.
    J Infect Dis. 2024 Jul 27:jiae381. doi: 10.1093.
    >> Share

  99. BURDORF RM, Zhou S, Amon C, Long N, et al
    Impact of Low-Frequency Human Immunodeficiency Virus Type 1 Drug Resistance Mutations on Antiretroviral Therapy Outcomes.
    J Infect Dis. 2024;230:86-94.
    >> Share

  100. GUITOR AK, Katyukhina A, Mokomane M, Lechiile K, et al
    Minimal Impact on the Resistome of Children in Botswana After Azithromycin Treatment for Acute Severe Diarrheal Disease.
    J Infect Dis. 2024;230:239-249.
    >> Share

  101. HENRY SA, Webster CM, Shaw LN, Torres NJ, et al
    Steroid Drugs Inhibit Bacterial Respiratory Oxidases and Are Lethal Toward Methicillin-Resistant Staphylococcus aureus.
    J Infect Dis. 2024;230:e149-e158.
    >> Share

  102. AUNG S, Novitsky V, Steingrimsson J, Gillani FS, et al
    Acquired Human Immunodeficiency Virus Type 1 Drug Resistance in Rhode Island, USA, 2004-2021.
    J Infect Dis. 2024 Jul 23:jiae344. doi: 10.1093.
    >> Share

  103. BLECHMAN SE, Wright ES
    Applications of machine learning on electronic health record data to combat antibiotic resistance.
    J Infect Dis. 2024 Jul 12:jiae348. doi: 10.1093.
    >> Share

  104. ZHOU S, Long N, Rosenke K, Jarvis MA, et al
    Combined Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Reduces Molnupiravir-Induced Mutagenicity and Prevents Selection for Nirmatrelvir/Ritonavir Resistance Mutations.
    J Infect Dis. 2024 Jul 8:jiae213. doi: 10.1093.
    >> Share

    June 2024
  105. CHOW EPF, Stevens K, De Petra V, Chen MY, et al
    Prevalence of cefixime-resistant Neisseria gonorrhoeae in Melbourne, Australia, 2021-2022.
    J Infect Dis. 2024 Jun 15:jiae313. doi: 10.1093.
    >> Share

  106. SOKAL A, Royer G, Esposito-Farese M, Clermont O, et al
    Clinical and Bacteriological Specificities of Escherichia coli Bloodstream Infections From Biliary Portal of Entries.
    J Infect Dis. 2024;229:1679-1687.
    >> Share

  107. DAI T, Ma C, Zhang F, Wang H, et al
    The Efficacy and Safety of an Intra-articular Dual-Acting Antibacterial Agent (TNP-2092) for Implant Infection-Associated Methicillin-Resistant Staphylococcus aureus.
    J Infect Dis. 2024;229:1658-1668.
    >> Share

  108. STRIZKI JM, Diamond TL, Teal VL, Gilbert CL, et al
    Cytomegalovirus antiviral resistance among participants in the phase 3 trial of letermovir vs valganciclovir prophylaxis in kidney transplant recipients.
    J Infect Dis. 2024 Jun 10:jiae287. doi: 10.1093.
    >> Share

    May 2024
  109. DIXIT A, Ektefaie Y, Kagal A, Freschi L, et al
    Drug resistance and epidemiological success of modern Mycobacterium tuberculosis lineages in western India.
    J Infect Dis. 2024 May 31:jiae240. doi: 10.1093.
    >> Share

  110. MCCLUSKEY SM, Muyindike WR, Nanfuka V, Omoding D, et al
    Population Effectiveness of Dolutegravir Implementation in Uganda - A Prospective Observational Cohort Study (DISCO): 48-week Results.
    J Infect Dis. 2024 May 16:jiae260. doi: 10.1093.
    >> Share

  111. TAGAMI Y, Horita N, Kaneko M, Muraoka S, et al
    Whole-Genome Sequencing Predicting Phenotypic Antitubercular Drug Resistance: Meta-analysis.
    J Infect Dis. 2024;229:1481-1492.
    >> Share

  112. KU JH, Tartof SY, Contreras R, Ackerson BK, et al
    Antibiotic resistance of urinary tract infection recurrences in a large U.S. integrated health care system.
    J Infect Dis. 2024 May 14:jiae233. doi: 10.1093.
    >> Share

  113. COSTA C, Sirard JC, Gibson PS, Veening JW, et al
    Triggering Toll-Like Receptor 5 signaling during pneumococcal superinfection prevents the selection of antibiotic resistance.
    J Infect Dis. 2024 May 8:jiae239. doi: 10.1093.
    >> Share

    April 2024
  114. MILLER WR, Nguyen A, Singh KV, Rizvi S, et al
    Membrane Lipids Augment Cell Envelope Stress Signaling via the MadRS System to Defend Against Antimicrobial Peptides and Antibiotics in Enterococcus faecalis.
    J Infect Dis. 2024 Apr 5:jiae173. doi: 10.1093.
    >> Share

    March 2024
  115. BROUGH SC, Caddell L, Liou RJ, Patil A, et al
    Predicting Increased Incidence of Common Antibiotic-Resistant and Antibiotic-Associated Pathogens Using Ensemble Species Distribution Modeling.
    J Infect Dis. 2024 Mar 27:jiae145. doi: 10.1093.
    >> Share

    February 2024
  116. PENG KT, Chen PC, Chen JL, Huang TY, et al
    A comparative phenotypic and genomic analysis of methicillin-resistant Staphylococcus aureus ST45 isolates from cellulitis and from osteomyelitis in Taiwan.
    J Infect Dis. 2024 Feb 26:jiae096. doi: 10.1093.
    >> Share

  117. SAUVE K, Watson A, Oh JT, Swift S, et al
    The Engineered Lysin, CF-370, is Active Against Antibiotic-Resistant Gram-Negative Pathogens In vitro and Synergizes with Meropenem in Experimental Pseudomonas aeruginosa Pneumonia.
    J Infect Dis. 2024 Feb 15:jiae027. doi: 10.1093.
    >> Share

  118. HENRY SA, Webster CM, Shaw LN, Torres NJ, et al
    Steroid Drugs Inhibit Bacterial Respiratory Oxidases and Are Lethal Toward Methicillin-Resistant Staphylococcus aureus.
    J Infect Dis. 2024 Feb 13:jiad540. doi: 10.1093.
    >> Share

    January 2024
  119. XIONG YQ, Li Y, Goncheva MI, Elsayed AM, et al
    The Purine Biosynthesis Repressor, PurR, Contributes to Vancomycin Susceptibility of Methicillin-resistant Staphylococcus aureus in Experimental Endocarditis.
    J Infect Dis. 2024 Jan 31:jiad577. doi: 10.1093.
    >> Share

  120. GIAMMARINO F, de Salazar A, Malet I, Vinuela L, et al
    Prevalence and phenotypic susceptibility to doravirine of the HIV-1 reverse transcriptase V106I polymorphism in B and non-B subtypes.
    J Infect Dis. 2024 Jan 11:jiae010. doi: 10.1093.
    >> Share

  121. VENTURINI C, Colston JM, Charles O, Lankina A, et al
    Persistent low-level variants in a subset of viral genes are highly predictive of poor outcome in immunocompromised patients with cytomegalovirus infection.
    J Infect Dis. 2024 Jan 5:jiae001. doi: 10.1093.
    >> Share

    December 2023
  122. SMITH RA, Raugi DN, Nixon RS, Seydi M, et al
    Antiviral Activity of Lenacapavir Against HIV-2 Isolates and Drug-resistant HIV-2 Mutants.
    J Infect Dis. 2023 Dec 7:jiad562. doi: 10.1093.
    >> Share

    November 2023
  123. PHILLIPS LT, Witney AA, Furegato M, Laing KG, et al
    Time Required for Nanopore Whole-Genome Sequencing of Neisseria gonorrhoeae for Identification of Phylogenetic Relationships.
    J Infect Dis. 2023;228:1179-1188.
    >> Share

    September 2023
  124. ANDREEV K, Jones JC, Seiler P, Kandeil A, et al
    Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Circulating Globally in 2022-2023.
    J Infect Dis. 2023 Sep 28:jiad418. doi: 10.1093.
    >> Share

    July 2023
  125. CHOU S, Alain S, Cervera C, Chemaly RF, et al
    Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients.
    J Infect Dis. 2023 Jul 28:jiad293. doi: 10.1093.
    >> Share

  126. HU Z, Cordwell T, Nguyen H, Li J, et al
    Effect of the L74I Polymorphism on Fitness of Cabotegravir-Resistant Variants of HIV-1 Subtype A6.
    J Infect Dis. 2023 Jul 27:jiad291. doi: 10.1093.
    >> Share

    June 2023
  127. SINGH DK, Bhaskar A, Pahuja I, Shaji A, et al
    Co-treatment with Clofazimine and Rapamycin eliminates drug-resistant tuberculosis by inducing polyfunctional central memory T cell responses.
    J Infect Dis. 2023 Jun 8:jiad214. doi: 10.1093.
    >> Share

    May 2023
  128. SCHALKWIJK HH, Georgala A, Gillemot S, Temblador A, et al
    A Herpes Simplex virus 1 DNA Polymerase Multidrug Resistance Mutation Identified in an Immunocompromised Patient - Confirmed by Gene Editing.
    J Infect Dis. 2023 May 24:jiad184. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016